Design of oncology clinical trials: A review

被引：14
|
作者：
Ananthakrishnan, Revathi
Menon, Sandeep
机构：
[1] #3 Cambridge, MA 02138
[2] #1 Newton, MA 02460, One Townhouse Drive
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2013年 / 88卷 / 01期
关键词：
Phases I; II and III oncology clinical trials; Trial designs; Safety and efficacy endpoints; PK/PD modeling; Statistical analyses; CONTINUAL REASSESSMENT METHOD; RESPONSE EVALUATION CRITERIA; ANTIBODY-DRUG CONJUGATE; TOXICITY TRADE-OFFS; PRACTICAL CONSIDERATIONS; TRASTUZUMAB EMTANSINE; HYPOTHESES SELECTION; INTERIM ANALYSES; DOSE-ESCALATION; 2-STAGE DESIGNS;
D O I：
10.1016/j.critrevonc.2013.03.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cancer is a disease that occurs due to the uncontrolled multiplication of cells that invade nearby tissues and can spread to other parts of the body. An increased incidence of cancer in the world has led to an increase in oncology research and in the number of oncology trials. Well designed oncology clinical trials are a key part of developing effective anti-cancer drugs. This-review focuses on statistical considerations in the design and analysis of oncology clinical trials. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：144 / 153
页数：10
相关论文
共 50 条
  • [31] Radiation oncology clinical trials
    Hynds, S.
    CLINICAL ONCOLOGY, 2007, 19 (03) : S32 - S33
  • [32] Adaptive clinical trials in oncology
    Donald A. Berry
    Nature Reviews Clinical Oncology, 2012, 9 : 199 - 207
  • [33] Clinical Trials in Hematology and Oncology
    Einsele, Hermann
    Steutel, Han
    Eichhorst, Barbara
    Gobeler, Maria-Elisabeth
    Hochhaus, Andreas
    Nickel, Lars
    von Messling, Veronika
    Deggerich, Anke
    Nettekoven, Gerd
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 : 6 - 32
  • [34] CLINICAL-TRIALS IN ONCOLOGY
    HOFFMANN, J
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1991, 46 (22): : 1553 - 1556
  • [35] Clinical trials of interventional oncology
    Yasuaki Arai
    International Journal of Clinical Oncology, 2012, 17 : 301 - 305
  • [36] CLINICAL TRIALS IN ONCOLOGY IN GREECE
    Mylona, K.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2011, 14 (07) : A467 - A467
  • [37] Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature
    Ellis, PM
    ANNALS OF ONCOLOGY, 2000, 11 (08) : 939 - 945
  • [38] Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials
    Ioakeim-Skoufa, Ignatios
    Tobajas-Ramos, Natalia
    Menditto, Enrica
    Aza-Pascual-Salcedo, Mercedes
    Gimeno-Miguel, Antonio
    Orlando, Valentina
    Gonzalez-Rubio, Francisca
    Fanlo-Villacampa, Ana
    Lasala-Aza, Carmen
    Ostasz, Ewelina
    Vicente-Romero, Jorge
    CANCERS, 2023, 15 (11)
  • [39] Implementation of artificial intelligence approaches in oncology clinical trials: A systematic review
    Saady, Marwa
    Eissa, Mahmoud
    Yacoub, Ahmed S.
    Hamed, Ahmed B.
    Azzazy, Hassan Mohamed El-Said
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2025, 161
  • [40] Critical Review of Umbrella, Basket, and Platform Designs for Oncology Clinical Trials
    Simon, Richard
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (06) : 934 - 941
12345